Off-Label Use and the Spectre of Drug-Eluting Stent Thrombosis

被引：1
|
作者：
Cook, Stephane [1 ]
Wenaweser, Peter [1 ]
机构：
[1] Swiss Cardiovasc Ctr, Bern, Switzerland
来源：
CIRCULATION-CARDIOVASCULAR INTERVENTIONS | 2009年 / 2卷 / 04期
关键词：
Editorials; stents; BARE-METAL STENTS; OUTCOMES; IMPLANTATION; PREDICTORS; EFFICACY; THERAPY; SAFETY; RISK;
D O I：
10.1161/CIRCINTERVENTIONS.109.891218
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：273 / 276
页数：4
相关论文
共 50 条
  • [1] The risk of definitive stent thrombosis is increased after "off-label" stent implantation irrespective of drug-eluting stent or bare-metal stent use
    Hoffmann, Rainer
    Klinker, Helene
    Adamu, Umar
    Kelm, Malte
    Blindt, Ruediger
    CLINICAL RESEARCH IN CARDIOLOGY, 2009, 98 (09) : 549 - 554
  • [2] Association Between Off-Label Use of Drug-Eluting Stents and Subsequent Stent Thrombosis: A Case-Control Analysis
    Rabinovitz, Asaf
    Bier, Dara M.
    Wagman, Gabriel M.
    Charlap, Esti
    Nazari, Reza
    Ghitelman, Jaime
    Celaj, Sulejman
    Skeif, Basel
    Menegus, Mark
    Srinivas, V. S.
    JOURNAL OF INVASIVE CARDIOLOGY, 2010, 22 (01) : 15 - 19
  • [3] The risk of definitive stent thrombosis is increased after “off-label” stent implantation irrespective of drug-eluting stent or bare-metal stent use
    Rainer Hoffmann
    Helene Klinker
    Umar Adamu
    Malte Kelm
    Rüdiger Blindt
    Clinical Research in Cardiology, 2009, 98 : 549 - 554
  • [4] On-Label and Off-Label Use of Drug-Eluting Stents Comparison of Short- and Long-Term Outcomes
    Poorhosseini, Hamidreza
    Kassaian, Seyed Ebrahim
    Aghajani, Hasan
    Alidoosti, Mohammad
    Hajizeinali, Ali Mohammad
    Salarifar, Mojtaba
    Nematipour, Ebrahim
    Amirzadegan, Ali Reza
    Sheikhfathollahi, Mahmood
    Shafiee, Nahid
    Hakki-Kazazi, Elham
    Tokaldany, Masoumeh Lotfi
    TEXAS HEART INSTITUTE JOURNAL, 2012, 39 (01): : 24 - 29
  • [5] Three Years Since the FDA Advisory Panel on Drug-Eluting Stents: What Have We Learned about Off-Label Use and Stent Thrombosis?
    Naidu, Srihari S.
    JOURNAL OF INVASIVE CARDIOLOGY, 2010, 22 (01) : 20 - 21
  • [6] Long-term outcomes following off-label use of sirolimus-eluting stent
    Kotani, Jun-ichi
    Ikari, Yuji
    Kyo, Eishou
    Nakamura, Masato
    Yokoi, Hiroyoshi
    JOURNAL OF CARDIOLOGY, 2013, 62 (3-4) : 151 - 157
  • [7] Long-Term Predictors of Clinical Events after Off-Label Use of Drug-Eluting Stent beyond 1 Year
    Yun, Kyeong Ho
    Ko, Jum Suk
    Rhee, Sang Jae
    Lee, Eun Mi
    Yoo, Nam Jin
    Kim, Nam-Ho
    Oh, Seok Kyu
    Jeong, Jin-Won
    KOREAN CIRCULATION JOURNAL, 2013, 43 (03) : 161 - 167
  • [8] Drug-eluting stent thrombosis: current and future perspectives
    Kuramitsu, Shoichi
    Sonoda, Shinjo
    Ando, Kenji
    Otake, Hiromasa
    Natsuaki, Masahiro
    Anai, Reo
    Honda, Yasuhiro
    Kadota, Kazushige
    Kobayashi, Yoshio
    Kimura, Takeshi
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2021, 36 (02) : 158 - 168
  • [9] Safety and efficacy of drug-eluting stents: On-label and off-label perspectives
    Weisz, Giora
    Stone, Gregg W.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2008, 9 (01) : 46 - 61
  • [10] Late Stent Thrombosis After Drug-Eluting Stent Seeing Is Understanding
    Wijns, William
    CIRCULATION, 2009, 120 (05) : 364 - 365
12345